North Central Cancer Treatment Group
The Comprehensive Clinical Brain Tumor Program is a member of the North Central Cancer Treatment group affiliated with the Mayo Clinic. All clinical trials available to the group are available to our patients locally or nationally. The list of open trials is constantly been updated. Updated lists can be obtained upon request.
Celldex vaccine for newly diagnosed GBMs
This phase II/III randomized trial enrolls patients with newly diagnosed GBMs for potential enrollment to receive CDX-110 vaccination at recurrence when EGFRvII positive.